The Efficacy and Safety of ALIC/NAcc-DBS for Treatment-refractory OCD

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 30, 2021

Primary Completion Date

November 13, 2023

Study Completion Date

January 29, 2024

Conditions
Obsessive-Compulsive Disorder
Interventions
DEVICE

deep brain stimulation

Both group will undergo the DBS surgery. Four weeks after surgery, all patients will visit the clinic with the DBS stimulation in the 'off' state for initial programming of electrical parameters for stimulation. At double-blind visit, the electrical stimulation will be actually 'turned on' immediately after the programming in true-stimulation group, while turn-off in the control group.

Trial Locations (7)

200030

Shanghai Mental Health Center, Shanghai

Unknown

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Brains Hospital of Hunan Province, Changsha

Changhai Hospital, Shanghai

Huashan Hospital, Shanghai

West China Hospital, Chengdu

The First Affiliated Hospital of Kunming Medical University, Kunming

All Listed Sponsors
collaborator

West China Hospital

OTHER

collaborator

Huashan Hospital

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

Hunan Brain Hospital

UNKNOWN

collaborator

First Affiliated Hospital of Kunming Medical University

OTHER

collaborator

Changhai Hospital

OTHER

collaborator

SceneRay Corporation, Limited

INDUSTRY

lead

Shanghai Mental Health Center

OTHER

NCT04967560 - The Efficacy and Safety of ALIC/NAcc-DBS for Treatment-refractory OCD | Biotech Hunter | Biotech Hunter